Cingulate Receives Complete Response Letter from FDA for CTx-1301
Go back to Cingulate Receives Complete Response Letter from FDA for CTx-1301| (NASDAQ: CING) | Delayed: 5.03 -0.06 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.09 | 52 Week High | $ | |||
| Open | $5.09 | 52 Week Low | $ | |||
| Day High | $5.17 | P/E | N/A | |||
| Day Low | $5.00 | EPS | $ | |||
| Volume | 51,707 | |||||
| (NASDAQ: CINGW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 100 | |||||
